105 related articles for article (PubMed ID: 3103386)
1. Pathology of MPTP in the marmoset.
Gibb WR; Lees AJ; Wells FR; Barnard RO; Jenner P; Marsden CD
Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
[No Abstract] [Full Text] [Related]
2. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
Jenner P; Rose S; Nomoto M; Marsden CD
Adv Neurol; 1987; 45():183-6. PubMed ID: 2881443
[No Abstract] [Full Text] [Related]
3. The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Gibb WR; Terruli M; Lees AJ; Jenner P; Marsden CD
Mov Disord; 1989; 4(1):53-74. PubMed ID: 2494438
[TBL] [Abstract][Full Text] [Related]
4. Administration of MPTP to the common marmoset does not alter cortical cholinergic function.
Garvey J; Petersen M; Waters CM; Rose SP; Hunt S; Briggs R; Jenner P; Marsden CD
Mov Disord; 1986; 1(2):129-34. PubMed ID: 3143064
[TBL] [Abstract][Full Text] [Related]
5. [The neurotoxic effect of MPTP and its mechanisms].
Xu XJ
Sheng Li Ke Xue Jin Zhan; 1988 Oct; 19(4):310-4. PubMed ID: 3074503
[No Abstract] [Full Text] [Related]
6. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
Burns RS; Markey SP; Phillips JM; Chiueh CC
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
Waters CM; Hunt SP; Jenner P; Marsden CD
Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of recovery in MPTP-induced parkinsonism.
Sandyk R
Neuroscience; 1988 Nov; 27(2):727-9. PubMed ID: 3146035
[No Abstract] [Full Text] [Related]
9. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
Hirata Y; Nagatsu T
Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
[No Abstract] [Full Text] [Related]
10. Effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/MPTP/on mouse substantia nigra in vitro. Fluorescence and electron microscopic examination.
Renkawek K
Prog Clin Biol Res; 1987; 253():255-63. PubMed ID: 3501590
[No Abstract] [Full Text] [Related]
11. Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.
Doudet D; Gross C; Lebrun-Grandie P; Bioulac B
Electromyogr Clin Neurophysiol; 1986 Dec; 26(8):711-27. PubMed ID: 3493894
[No Abstract] [Full Text] [Related]
12. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
13. Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP.
Chen SD; Xu DL; Yu HZ; Tang QM; Xu XR; Wang ZG; Liang PF
Chin Med J (Engl); 1988 Dec; 101(12):879-83. PubMed ID: 3150735
[No Abstract] [Full Text] [Related]
14. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.
Chiueh CC; Markey SP; Burns RS; Johannessen JN; Jacobowitz DM; Kopin IJ
Psychopharmacol Bull; 1984; 20(3):548-53. PubMed ID: 6332333
[No Abstract] [Full Text] [Related]
15. Chronic administration of MPTP to marmosets.
Albanese A; Altavista MC; Gozzo S; Rossi P; Colosimo C; Bentivoglio AR; Perretta G; Elia M; Monaco V; Macchi G
Adv Neurol; 1990; 53():239-44. PubMed ID: 1978517
[No Abstract] [Full Text] [Related]
16. [Parkinsonism and MPTP (methylphenyltetrahydropyridine)].
Nagatsu T
No To Shinkei; 1986 Jul; 38(7):706-7. PubMed ID: 3489476
[No Abstract] [Full Text] [Related]
17. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
Collins MA; Neafsey EJ; Cheng BY; Hurley-Gius K; Ung-Chhun NA; Pronger DA; Christensen MA; Hurley-Gius D
Adv Neurol; 1987; 45():179-82. PubMed ID: 3493625
[No Abstract] [Full Text] [Related]
18. MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity.
Bocchetta A; Piccardi MP; Zuddas A; Bernardi F; Zompo MD; Corsini GU
Funct Neurol; 1988; 3(4):439-47. PubMed ID: 3072279
[No Abstract] [Full Text] [Related]
19. MPTP: current concepts and controversies.
Langston JW; Irwin I
Clin Neuropharmacol; 1986; 9(6):485-507. PubMed ID: 3542203
[No Abstract] [Full Text] [Related]
20. [MPTP and Parkinson's disease].
Imai H
No To Shinkei; 1988 Nov; 40(11):1011-24. PubMed ID: 3064783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
